Cardioprotective Potential of Coumestrol Against Beryllium Sulfate Induced Cardiotoxicity via Modulating IRAK1/TRAF6 and TLR4/MyD88 Axis in Sprague Dawley Rats

Beryllium sulfate (BeSO<sub>4</sub>) is one of the leading members of beryllium family that can exert toxic effects via disrupting key signaling pathways and redox profile. Coumestrol (CML) is a polyphenolic compound with exceptional biological properties. This pre-clinical investigation was performed to explore the cardioprotective ability of CML against BeSO<sub>4</sub> induced sub-chronic cardiotoxicity. Thirty-six male Sprague Dawley rats were categorized into distinct groups as follows: control, BeSO<sub>4</sub> (12 mg kg<sup>-1</sup>), BeSO<sub>4</sub> (12 mg kg<sup>-1</sup>) + CML (5 mg kg<sup>-1</sup>), and CML (5 mg kg<sup>-1</sup>) treated group. It was observed that BeSO<sub>4</sub> administration upregulated the expression of cyclooxygenase-2 (COX-2), interleukin-1 receptor-associated kinase1 (IRAK1), toll-like receptor4 (TLR4), myeloid differentiation primary response protein88 (MyD88), nuclear factor-kappa B (NF-κB), tumor necrosis factor receptor-associated factor6 (TRAF6), tumor necrosis factor-alpha (TNF-α), IκB kinase (IKK), and interleukin-1 beta (IL-1β), while suppressing the expression of inhibitor of nuclear factor kappa B alpha (IκBα). The redox profile was altered through a significant reduction in enzymatic activities of HO-1, GPx, CAT, GSR, GST, and SOD, while a sudden escalation in the levels of ROS and MDA after BeSO<sub>4</sub> intoxication. The levels of cardiac injury markers such as ProBNP, CK-MB, CPK, C-reactive protein, troponin-T, LDH, troponin-I and BNP were elevated following the administration of BeSO<sub>4</sub>. Besides, BeSO<sub>4</sub> exposure increased the levels of Caspase-9, Bax, and Caspase-3 while reducing the levels of Bcl-2. Cardiac histology showed severe disruptions in BeSO<sub>4</sub> treated rats. Nonetheless, CML therapy alleviated aforementioned disruptions via regulating redox balance, inflammatory and apoptotic profile of cardiac tissues. These findings suggest that CML could be employed in clinical research to validate these findings in humans.

Authors

Institutions

Publication Details

Journal
Journal of Biochemical and Molecular Toxicology
Published
2025-12-30
DOI
https://doi.org/10.1002/jbt.70671
Citations
1
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardioprotective Potential of Coumestrol Against Beryllium Sulfate Induced Cardiotoxicity via Modulating IRAK1/TRAF6 and TLR4/MyD88 Axis in Sprague Dawley Rats

Fuad Alzahrani, H. Mohammed Hassan, Khalaf F. Alsharif, Khalid J. Alzahrani et al.
1 citations
Journal of Biochemical and Molecular Toxicology
Sarcoidosis and Beryllium Toxicity Research
1.16
article

Cardioprotective Potential of Coumestrol Against Beryllium Sulfate Induced Cardiotoxicity via Modulating IRAK1/TRAF6 and TLR4/MyD88 Axis in Sprague Dawley Rats

Fuad Alzahrani, H. Mohammed Hassan, Khalaf F. Alsharif, Khalid J. Alzahrani, Muhammad Usman Hayder, Arifa Mehreen
article en
1 citations

Abstract

Beryllium sulfate (BeSO<sub>4</sub>) is one of the leading members of beryllium family that can exert toxic effects via disrupting key signaling pathways and redox profile. Coumestrol (CML) is a polyphenolic compound with exceptional biological properties. This pre-clinical investigation was performed to explore the cardioprotective ability of CML against BeSO<sub>4</sub> induced sub-chronic cardiotoxicity. Thirty-six male Sprague Dawley rats were categorized into distinct groups as follows: control, BeSO<sub>4</sub> (12 mg kg<sup>-1</sup>), BeSO<sub>4</sub> (12 mg kg<sup>-1</sup>) + CML (5 mg kg<sup>-1</sup>), and CML (5 mg kg<sup>-1</sup>) treated group. It was observed that BeSO<sub>4</sub> administration upregulated the expression of cyclooxygenase-2 (COX-2), interleukin-1 receptor-associated kinase1 (IRAK1), toll-like receptor4 (TLR4), myeloid differentiation primary response protein88 (MyD88), nuclear factor-kappa B (NF-κB), tumor necrosis factor receptor-associated factor6 (TRAF6), tumor necrosis factor-alpha (TNF-α), IκB kinase (IKK), and interleukin-1 beta (IL-1β), while suppressing the expression of inhibitor of nuclear factor kappa B alpha (IκBα). The redox profile was altered through a significant reduction in enzymatic activities of HO-1, GPx, CAT, GSR, GST, and SOD, while a sudden escalation in the levels of ROS and MDA after BeSO<sub>4</sub> intoxication. The levels of cardiac injury markers such as ProBNP, CK-MB, CPK, C-reactive protein, troponin-T, LDH, troponin-I and BNP were elevated following the administration of BeSO<sub>4</sub>. Besides, BeSO<sub>4</sub> exposure increased the levels of Caspase-9, Bax, and Caspase-3 while reducing the levels of Bcl-2. Cardiac histology showed severe disruptions in BeSO<sub>4</sub> treated rats. Nonetheless, CML therapy alleviated aforementioned disruptions via regulating redox balance, inflammatory and apoptotic profile of cardiac tissues. These findings suggest that CML could be employed in clinical research to validate these findings in humans.

Journal of Biochemical and Molecular ToxicologyVol. 40(1)
Taif University (SA), University of Faisalabad (PK), University of Agriculture Faisalabad (PK), King Khalid University (SA)
Openalex Percentile: Top 15%
Sarcoidosis and Beryllium Toxicity Research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.